Comparison of the efficacy and safety of 4 and 2 mg/day brexpiprazole for acute schizophrenia: a meta-analysis of double-blind, randomized placebo-controlled trials
about
Comparison of the efficacy and safety of 4 and 2 mg/day brexpiprazole for acute schizophrenia: a meta-analysis of double-blind, randomized placebo-controlled trials
description
im Oktober 2018 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 October 2018
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2018
@uk
name
Comparison of the efficacy and ...... ized placebo-controlled trials
@en
Comparison of the efficacy and ...... ized placebo-controlled trials
@nl
type
label
Comparison of the efficacy and ...... ized placebo-controlled trials
@en
Comparison of the efficacy and ...... ized placebo-controlled trials
@nl
prefLabel
Comparison of the efficacy and ...... ized placebo-controlled trials
@en
Comparison of the efficacy and ...... ized placebo-controlled trials
@nl
P2093
P2860
P356
P1476
Comparison of the efficacy and ...... ized placebo-controlled trials
@en
P2093
Ikuo Nomura
Kazuto Oya
Kenji Sakuma
Kiyoshi Fujita
Makoto Okuya
Reiji Yoshimura
Toshihiko Funahashi
Yuki Matsuda
Yuki Matsui
P2860
P304
P356
10.2147/NDT.S176676
P407
P577
2018-10-01T00:00:00Z